To view this email as a web page, click here.
November 7, 2017
 
ADVERTISEMENT
 
PHARMACISTS' REPORT
 
Pharmacists Help Boost Adherence Rates
Vanderbilt Specialty Pharmacy has created a model to integrate its pharmacists into its specialty clinics.
Read more
 
The Underappreciated Risks of Hospital IV Compounding
With a 9% error rate, it’s time for IV compounding to move into the future.
Read more
 
11 of the Weirdest Medical Facts Ever Believed
From the Drug Topics archives, one of most popular features in our history returns.
Read more
 
Edaravone (Radicava) for ALS
Edaravone has been approved for patients with amyotropic lateral sclerosis.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.